Lista de obras - João Pedro Ferreira - Dominio Público Uruguay

A Systematic Assessment of Absolute Treatment Effect.

artículo científico publicado en 2015

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

scientific article published on 01 November 2019

Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study

scientific article published on 01 July 2019

Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus

artículo científico publicado en 2018

Antineutrophil cytoplasmatic antibody positive systemic vasculitis in a patient treated with propylthiouracil.

artículo científico publicado en 2013

Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.

artículo científico publicado en 2016

Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort

artículo científico publicado en 2018

Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk My

artículo científico publicado en 2016

Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!

artículo científico publicado en 2019

Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches

artículo científico publicado en 2020

Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial

artículo científico publicado en 2020

Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial

scientific article published on 29 November 2019

Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post-hoc analysis of the Aldo-DHF trial

artículo científico publicado en 2020

Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF study

scientific article published on 02 December 2019

Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study

scientific article published on 26 June 2019

Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial

scientific article published on 04 January 2020

Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study

artículo científico publicado en 2019

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure

artículo científico publicado en 2020

Cohort Profile: Rationale and design of the fourth visit of the STANISLAS Cohort: a familial longitudinal population-based cohort from the Nancy region of France

artículo científico publicado en 2017

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial

artículo científico publicado en 2018

Coronary angiography in worsening heart failure: determinants, findings and prognostic implications

artículo científico publicado en 2017

Correction to: Prognostic value of estimated plasma volume in acute heart failure in three cohort studies

article

Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients

scientific article published on 30 April 2020

Covariate adjusted reanalysis of the I-Preserve trial

artículo científico publicado en 2020

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns

scientific article published on 01 July 2018

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients wit

artículo científico publicado en 2019

Distinct Pathological Pathways in Patients With Heart Failure and Diabetes

artículo científico publicado en 2020

Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study

artículo científico publicado en 2018

Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction

artículo científico publicado en 2018

Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

artículo científico publicado en 2020

Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGi

scientific article published on 16 January 2020

Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline

artículo científico publicado en 2019

Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)

artículo científico publicado en 2020

Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial

scientific article published on 03 September 2019

Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

scientific article published on 03 April 2020

Estimated Long-Term Survival With Eplerenone

scientific article published on 01 May 2019

Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness.

artículo científico publicado en 2006

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure

scientific article published on 12 July 2019

Extracting Meaning of Tubular Injury Molecules: Implications for Cardiorenal Health

artículo científico publicado en 2019

Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings

scientific article published on 31 May 2018

Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study

scientific article published on 29 January 2020

Head-to-head comparison of clustering methods for heterogeneous data: a simulation-driven benchmark

scientific article published on 18 February 2021

Heart failure and atrial fibrillation: from basic science to clinical practice

artículo científico publicado en 2015

Heart failure around the world

scientific article published on 16 August 2019

Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF

scientific article published on 08 November 2019

Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study

artículo científico publicado en 2018

Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort

scientific article published on 02 December 2019

High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60

artículo científico publicado en 2016

High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients

artículo científico publicado en 2014

Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey.

artículo científico publicado en 2017

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials

scientific article published on 27 September 2018

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis

scientific article published on 06 February 2019

Income level and inequality as complement to geographical differences in cardiovascular trials

scientific article published on 01 September 2019

Interpretation of the ATHENA Trial-Caveats and Future Directions

artículo científico publicado en 2017

Investigating a Case of Recurrent Pleural Effusion ⬇️

artículo científico publicado el 15 de octubre de 2011

Is Sacubitril/Valsartan Antifibrotic?

scientific article published on 01 February 2019

Left-sided infective endocarditis: analysis of in-hospital and medium-term outcome and predictors of mortality.

artículo científico publicado en 2013

Longer Duration of Hypertension and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension

artículo científico publicado en 2020

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT

artículo científico publicado en 2019

Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative

scientific article published on 05 April 2019

Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study.

artículo científico publicado en 2017

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

scientific article published on 26 November 2020

Meticilin resistant Staphylococcus aureus and liver abscess: a retrospective analysis of 117 patients

artículo científico publicado en 2011

Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure

artículo científico publicado en 2019

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

scientific article published on 08 January 2020

Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.

artículo científico publicado en 2013

Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.

artículo científico publicado en 2017

Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial

scientific article published on 13 August 2020

Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial

artículo científico publicado en 2020

NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial

artículo científico publicado en 2017

Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF

artículo científico publicado en 2020

Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials.

artículo científico publicado en 2016

Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study)

scientific article published on 01 June 2019

Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort

scientific article published on 21 April 2018

Oxygen therapy: a clinical audit in an Internal Medicine Department

artículo científico publicado en 2015

PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort

scientific article published on 25 March 2020

Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?

artículo científico publicado en 2018

Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses

scientific article published on 06 May 2019

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments

artículo científico publicado en 2019

Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

scientific article published on 18 August 2018

Practical management of concomitant acute heart failure and worsening renal function in the emergency department

artículo científico publicado en 2017

Prediction of Heart Failure Outcomes in Patients with Type 2 Diabetes Mellitus: Validation of the TRS-HF<sub>DM</sub> Score in the ACCORD Trial

scientific article published on 02 December 2020

Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation.

artículo científico publicado en 2016

Predictors of sudden cardiac death in high-risk patients following a myocardial infarction

artículo científico publicado en 2020

Prognostic value of estimated plasma volume in acute heart failure in three cohort studies

article

Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure

scientific article published on 01 May 2019

Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

artículo científico publicado en 2017

Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial

scientific article published on 01 May 2020

Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points

article

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial

scientific article published on 15 February 2019

Renin-angiotensin-aldosterone system and kidney interactions in heart failure

artículo científico publicado en 2019

Reply: Cardiopulmonary Exercise Testing Versus 6-Min Walk Test as Clinically Meaningful Endpoints in HF Trials

artículo científico publicado en 2017

Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study

artículo científico publicado en 2017

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

scientific article published on 28 August 2020

Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative

artículo científico publicado en 2017

Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials

artículo científico publicado en 2020

Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trial

scientific article published on 01 April 2020

Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.

artículo científico publicado en 2015

Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation

artículo científico publicado en 2018

Survival after bilateral internal mammary artery in coronary artery bypass grafting: Are women at risk?

artículo científico publicado en 2018

Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.

artículo científico publicado en 2013

The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis

artículo científico publicado en 2017

The intersecting role of glycaemia and cardiac function in the development of heart failure among patients with type 2 diabetes mellitus after an acute coronary syndrome

scientific article published on 30 April 2020

The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE

scientific article published on 30 April 2020

The role of albuminuria as a non-invasive marker for congestive acutely decompensated chronic heart failure and the spironolactone effect in elderly Portuguese: a non-randomized trial

artículo científico publicado en 2014

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

artículo científico publicado en 2024

Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial

artículo científico publicado en 2020

Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials

artículo científico publicado en 2018

World Heart Federation Roadmap for Heart Failure

scientific article published on 01 September 2019

Lista de obras de João Pedro Ferreira

A Systematic Assessment of Absolute Treatment Effect.

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study

Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus

Antineutrophil cytoplasmatic antibody positive systemic vasculitis in a patient treated with propylthiouracil.

Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.

Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort

Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk My

Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!

Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches

Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial

Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial

Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post-hoc analysis of the Aldo-DHF trial

Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF study

Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study

Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial

Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure

Cohort Profile: Rationale and design of the fourth visit of the STANISLAS Cohort: a familial longitudinal population-based cohort from the Nancy region of France

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial

Coronary angiography in worsening heart failure: determinants, findings and prognostic implications

Correction to: Prognostic value of estimated plasma volume in acute heart failure in three cohort studies

Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients

Covariate adjusted reanalysis of the I-Preserve trial

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients wit

Distinct Pathological Pathways in Patients With Heart Failure and Diabetes

Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study

Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction

Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGi

Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline

Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)

Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial

Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

Estimated Long-Term Survival With Eplerenone

Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness.

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure

Extracting Meaning of Tubular Injury Molecules: Implications for Cardiorenal Health

Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings

Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study

Head-to-head comparison of clustering methods for heterogeneous data: a simulation-driven benchmark

Heart failure and atrial fibrillation: from basic science to clinical practice

Heart failure around the world

Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF

Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study

Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort

High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60

High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients

Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey.

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis

Income level and inequality as complement to geographical differences in cardiovascular trials

Interpretation of the ATHENA Trial-Caveats and Future Directions

Investigating a Case of Recurrent Pleural Effusion ⬇️

Is Sacubitril/Valsartan Antifibrotic?

Left-sided infective endocarditis: analysis of in-hospital and medium-term outcome and predictors of mortality.

Longer Duration of Hypertension and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT

Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative

Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study.

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

Meticilin resistant Staphylococcus aureus and liver abscess: a retrospective analysis of 117 patients

Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.

Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.

Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial

Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial

NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial

Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF

Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials.

Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study)

Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort

Oxygen therapy: a clinical audit in an Internal Medicine Department

PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort

Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?

Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments